title: [Schnitzler syndrome: A dramatic improvement with anakinra].
authors.forename: Thierry
authors.initials: T
authors.lastname: Billey
authors.forename: Mounir
authors.initials: M
authors.lastname: Beldjerd
authors.forename: Luciana
authors.initials: L
authors.lastname: Popa
authors.forename: Slim
authors.initials: S
authors.lastname: Lassoued
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D007279:Injections, Subcutaneous; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D017472:Receptors, Interleukin-1 / Q000819:agonists; D019873:Schnitzler Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D007075:Immunoglobulin M; D007145:Immunoglobulin kappa-Chains; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1